Jabre Capital Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-35,900	Closed	-$1.83M	–	171
2018 Q1	$1.83M	Buy	+35,900	New	+$1.83M	0.39%	65